semaglutide and visceral fat GLP-1 drugs are often framed as weight-loss drugs, but that perspective overlooks their deeper biology. Randomized trials show meaningful effects on cardiovascular events, fat, kidney health, inflammation. already has Before and After Semaglutide GLP-1

How investigative journalist Gary Taubes learned to spot bad science in nutrition, why that matters for your health decisions, and how to think more like a careful scientist yourself.

Benefits: Helps reduce stubborn fat, supports cardiovascular and immune health, promotes digestion, and contributes to long-term metabolic and weight management

Discover fat-burning workouts to enhance weight loss and energy.

Feeling drained on GLP-1 medications

The general recommendation for a sample size to assess the safety of a weight-reduction drug is 3,000 subjects randomized to the investigational drug within the to-be258 recommended dosage range and no fewer than 1,500 subjects randomized to placebo for at least 1 year of treatment at the maintenance dosage Multiple #obesitytrials have successfully used flexible dosing regimens

There is no direct clinical evidence that digestive enzymes lower LDL cholesterol